2009 Asia Pacific Frost & Sullivan
Product Differentiation Excellence Award for In-Vitro Diagnostics
“The recipient has built a ground breaking EFAD chip technology that has the potential to revolutionize the practice of clinical and point-of-care diagnostics in the in-vitro diagnostics market. The key differentiator of this technology is the use of a dielectric material that helps to prevent adverse electrochemical effects which can reduce the sensitivity and increase the accuracy of detection. The product has been developed by a world-class team of scientists, engineers and technologists and is supported by an esteemed Scientific Advisory Board.
This award recognizes the recipient for its ability to develop advanced products with differentiated capabilities.
The recipient of the 2009 Asia Pacific Frost & Sullivan Product Differentiation Excellence Award for In-Vitro Diagnostics –
Hai Kang Life Corporation”
From Frost & Sullivan
What is EFAD Chip?
EFADchip stands for Electric Field Assisted Diagnostic chip, Hai Kang Life’s latest product innovation in biotechnology, utilizing patented technology to produce rapid and sensitive results in diagnostics.
What is significant about EFADchip?
EFADchip delivers a simple and reliable platform testing system, providing a scalable and cost-effective solution for point-of-care applications and individualized medicine. Hai Kang Life’s innovative development of EFADchip serves to address and overcome barriers with current clinical diagnostic and testing. EFADchip is:
Designed for widespread adoption
Requires only small volumes of reagents
Does not involve complex signal detection
Programmable and fully automated system
Multiple diagnosis for more than 300 targets
How will EFADchip technology contribute to the future of healthcare?
Hai Kang Life’s Lab-on-a-Chip technology demonstrates increased suitability for improving patient care over the conventional testing process by optimizing the patient–doctor relationship, allowing testing results and interpretation within minutes
To find out more about EFADchip technology, please read “The Opportunities and Future of Lab-on-A-Chip Technology in Diagnostics: A White Paper” (Frost and Sullivan, 2009).
Hai Kang Life Corporation Limited incorporates the development of a novel electric field assisted diagnostic chip (EFADchip) technology into a fully-functional platform that will revolutionize the practice of clinical and PoC diagnostics and establish Hai Kang Life Corporation Limited as a prominent player in driving Asia Pacific into the globally competitive biotechnology arena.
2009 Asia Pacific Frost & Sullivan Product Differentiation Excellence Award
for In-Vitro Diagnostics to Hai Kang Life Corporation Limited.
Frost and Sullivan interviews Professor Albert Yu, Chairman and Chief Executive Officer of Hai Kang Life Corporation Limited
For further information, please contact
Kinnie Ho
International Relations & Project Development Manager
Telephone: +852 2111 2123 Kinnie.ho@haikanglife.com
About Hai Kang Life Corporation Limited:
Hai Kang Life Corporation Limited, formerly known as Hong Kong DNA Chips, was established with independent research funding in 1999. The company is strategically positioned at the hub of Asian biotechnology, equipped with the most advanced research and production facilities in both Beijing and Hong Kong. Strong working relationships with academic institutions, government and industry partners have created a solid foundation for business success. The world-class team of scientists, engineers and technologists, supported by a highly esteemed Scientific Advisory Board, is committed to maintaining HKLife’s position at the forefront of bio-business, leveraging best practices from both East and West.
